LFG
MRNA icon

Larson Financial Group’s Moderna MRNA Stock Holding History

Larson Financial Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136K Sell
1,943
-223
-10% -$11.5K ﹤0.01% 1023
2026
Q1 		$110K Buy
2,166
+336
+18% +$15.7K ﹤0.01% 949
2025
Q4 		$54K Sell
1,830
-305
-14% -$8.29K ﹤0.01% 1191
2025
Q3 		$55.1K Sell
2,135
-343
-14% -$9.57K ﹤0.01% 1119
2025
Q2 		$68.4K Sell
2,478
-106
-4% -$2.79K ﹤0.01% 963
2025
Q1 		$73.3K Buy
2,584
+1,318
+104% +$46.8K ﹤0.01% 881
2024
Q4 		$52.6K Buy
1,266
+356
+39% +$17K ﹤0.01% 885
2024
Q3 		$60.8K Buy
910
+317
+53% +$29.1K ﹤0.01% 851
2024
Q2 		$70.4K Buy
593
+561
+1,753% +$71K ﹤0.01% 731
2024
Q1 		$3.41K Hold
32
– – ﹤0.01% 1269
2023
Q4 		$3.18K Sell
32
-83
-72% -$6.98K ﹤0.01% 1284
2023
Q3 		$11.9K Sell
115
-8
-7% -$892 ﹤0.01% 951
2023
Q2 		$14.9K Buy
123
+4
+3% +$534 ﹤0.01% 820
2023
Q1 		$18.3K Hold
119
– – ﹤0.01% 763
2022
Q4 		$21.4K Hold
119
– – ﹤0.01% 681
2022
Q3 		$14K Hold
119
– – ﹤0.01% 707
2022
Q2 		$17K Buy
119
+8
+7% +$1.14K ﹤0.01% 583
2022
Q1 		$19K Sell
111
-70
-39% -$11.8K ﹤0.01% 540
2021
Q4 		$46K Buy
181
+40
+28% +$11.7K 0.01% 395
2021
Q3 		$54K Buy
141
+40
+40% +$14.8K 0.01% 283
2021
Q2 		$24K Sell
101
-36
-26% -$6.43K 0.01% 401
2021
Q1 		$18K Buy
137
+11
+9% +$1.59K 0.01% 434
2020
Q4 		$13K Sell
126
-1,128
-90% -$114K ﹤0.01% 456
2020
Q3 		$89K Sell
1,254
-298
-19% -$20.8K 0.04% 137
2020
Q2 		$100K Buy
1,552
+1,535
+9,029% +$84.1K 0.05% 134
2020
Q1 		$1K Buy
+17
New +$391 ﹤0.01% 491

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Larson Financial Group's MRNA Position: Q2 2026 in Review

Larson Financial Group reduced its Moderna (MRNA) stake by 10% in Q2 2026, selling an estimated $11.5K and leaving 1,943 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #1023.

Larson Financial Group first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Larson Financial Group held 1,943 shares of Moderna worth $136K as of Q2 2026.
  • Larson Financial Group sold 223 Moderna shares in Q2 2026, an estimated $11.5K.
  • Moderna made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1023 holding.
  • Larson Financial Group first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.